secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0000950170-24-083765
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics effects 1-for-10 reverse stock split effective July 17, 2024
--------------------------------------------------------------------------------

- Reverse split effective July 17, 2024 at 5:00 PM ET; every 10 pre-split shares become 1 post-split share.
- Stockholders approved reverse split at June 6, 2024 annual meeting; board set 1-for-10 ratio on June 26, 2024.
- Ticker TCRT unchanged; new CUSIP 98973P309; trading on split-adjusted basis from July 18, 2024.
- Equiniti Trust Company appointed as exchange agent to handle shareholder share exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024083765/0000950170-24-083765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024083765/tcrt-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-083765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer